Free Trial Information
BioCentury | Mar 3, 2011
Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Cancer CD70 (CD27L) Studies in mice and in cell culture suggest that CD70-targeted T cell immunotherapy could help treat CD70+...
Read More
BioCentury | May 27, 2010
Targets & Mechanisms

Coaxing cancer to defect

...The specific factors targeted in those studies were SMG1 homolog phosphatidylinositol 3-kinase related kinase ( SMG1...
...cells transduced with a lentiviral vector expressing small hairpin RNAs that targeted the NMD factors Smg1...
...the technique could treat existing tumors. Gilboa and colleagues conjugated small interfering RNA against either Smg1...
Read More
BioCentury | Jun 7, 1999
Company News

Quintiles, Minerva Medical plc, SMG Marketing Group Inc. deal

QTRN acquired Minerva, a CRO, in a pooling-of-interests stock transaction. Minerva will operate under its own name as a specialty business unit of QTRN's Quintiles Product Development group. Separately, QTRN acquired SMG, a healthcare market...
Read More
Items per page:
1 - 3 of 3